1. Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes
   Paul Peixoto et al, 2019, Cells CrossRef
2. Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
   Giorgio Milazzo et al, 2020, Genes CrossRef
3. Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
   Filipa Moreira-Silva et al, 2020, Pharmaceutics CrossRef
4. Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
   Michel Montalvo-Casimiro et al, 2020, Front. Oncol. CrossRef
5. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
   Mariarosaria Conte et al, 2020, Marine Drugs CrossRef
6. Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
   Pavel Hurník et al, 2022, Front. Genet. CrossRef
7. Toxicity Predictions for Mycotoxins: A Combined In Silico Approach on Enniatin-Like Cluster
   Denis Habauzit et al, 2022, Expo Health CrossRef
8. Subclass-Specific Prognosis and Treatment Efficacy Inference in Head and Neck Squamous Carcinoma
   Zetian Zheng et al, 2022, IEEE J. Biomed. Health Inform. CrossRef
9. Pathological Role of HDAC8: Cancer and Beyond
   Ji Yoon Kim et al, 2022, Cells CrossRef
10. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
    Xun Zhou et al, 2023, Front. Immunol. CrossRef
11. The role of acetylation of histone H3 and H4 in oral squamous cell carcinoma
    Lian Li et al, 2023 CrossRef
12. The Current Scenario of Nature-Derived Cyclopeptides with Anticancer Potential (A Review)
    B.-s. Liu et al, 2024, Russ J Gen Chem CrossRef
13. In Vitro Testing of Lung Carcinogenicity for an In Silico-Identified Cluster of Mycotoxins
    Denis Habauzit et al, 2024, Expo Health CrossRef
14. Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions
    Mohammed Alrouji et al, 2024, Front. Pharmacol. CrossRef